CUMBERLAND PHARMACEUTICALS INC Quarterly Other Assets, Current in USD from Q4 2010 to Q3 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of current assets classified as other.
Summary
Cumberland Pharmaceuticals Inc quarterly Other Assets, Current history and growth rate from Q4 2010 to Q3 2023.
  • Cumberland Pharmaceuticals Inc Other Assets, Current for the quarter ending September 30, 2023 was $1.97M, a 47.3% decline year-over-year.
Other Assets, Current, Quarterly (USD)
Other Assets, Current, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2023 $1.97M -$1.77M -47.3% Sep 30, 2023 10-Q 2023-11-13
Q2 2023 $2.28M -$558K -19.7% Jun 30, 2023 10-Q 2023-08-11
Q1 2023 $2.72M -$846K -23.7% Mar 31, 2023 10-Q 2023-05-12
Q4 2022 $3.08M -$255K -7.64% Dec 31, 2022 10-Q 2023-11-13
Q3 2022 $3.74M +$2.48M +197% Sep 30, 2022 10-Q 2022-11-14
Q2 2022 $2.84M +$1.08M +61.3% Jun 30, 2022 10-Q 2022-08-12
Q1 2022 $3.56M +$1.66M +87.4% Mar 31, 2022 10-Q 2022-05-13
Q4 2021 $3.34M +$1.14M +51.8% Dec 31, 2021 10-Q 2022-11-14
Q3 2021 $1.26M -$519K -29.2% Sep 30, 2021 10-Q 2021-11-12
Q2 2021 $1.76M -$327K -15.7% Jun 30, 2021 10-Q 2021-08-13
Q1 2021 $1.9M -$419K -18.1% Mar 31, 2021 10-Q 2021-05-14
Q4 2020 $2.2M -$558K -20.2% Dec 31, 2020 10-Q 2021-11-12
Q3 2020 $1.78M -$214K -10.8% Sep 30, 2020 10-Q 2020-11-13
Q2 2020 $2.09M -$340K -14% Jun 30, 2020 10-Q 2020-08-14
Q1 2020 $2.32M -$138K -5.6% Mar 31, 2020 10-Q 2020-05-22
Q4 2019 $2.76M -$206K -6.96% Dec 31, 2019 10-Q 2020-11-13
Q3 2019 $1.99M -$359K -15.3% Sep 30, 2019 10-Q 2019-11-13
Q2 2019 $2.43M -$361K -13% Jun 30, 2019 10-Q 2019-08-14
Q1 2019 $2.46M -$531K -17.8% Mar 31, 2019 10-Q 2019-05-15
Q4 2018 $2.96M -$503K -14.5% Dec 31, 2018 10-Q 2019-11-13
Q3 2018 $2.35M -$594K -20.2% Sep 30, 2018 10-Q 2018-11-14
Q2 2018 $2.79M +$127K +4.77% Jun 30, 2018 10-Q 2018-08-14
Q1 2018 $2.99M +$480K +19.1% Mar 31, 2018 10-Q 2018-05-09
Q4 2017 $3.47M +$756K +27.9% Dec 31, 2017 10-Q 2018-11-14
Q3 2017 $2.95M -$2.21M -42.9% Sep 30, 2017 10-Q 2017-11-08
Q2 2017 $2.66M -$1.46M -35.4% Jun 30, 2017 10-Q 2017-08-09
Q1 2017 $2.51M -$2.21M -46.9% Mar 31, 2017 10-Q 2017-05-15
Q4 2016 $2.71M -$1.29M -32.2% Dec 31, 2016 10-Q 2017-11-08
Q3 2016 $5.16M +$198K +3.99% Sep 30, 2016 10-Q 2016-11-03
Q2 2016 $4.12M -$403K -8.91% Jun 30, 2016 10-Q 2016-08-05
Q1 2016 $4.72M -$107K -2.21% Mar 31, 2016 10-Q 2016-05-13
Q4 2015 $4M -$1M -20.1% Dec 31, 2015 10-Q 2016-11-03
Q3 2015 $4.96M +$518K +11.7% Sep 30, 2015 10-Q 2015-11-06
Q2 2015 $4.52M +$776K +20.7% Jun 30, 2015 10-Q 2015-08-07
Q1 2015 $4.83M +$979K +25.5% Mar 31, 2015 10-Q 2015-05-15
Q4 2014 $5M +$1.47M +41.4% Dec 31, 2014 10-Q 2015-11-06
Q3 2014 $4.44M +$979K +28.2% Sep 30, 2014 10-Q 2014-11-07
Q2 2014 $3.74M +$547K +17.1% Jun 30, 2014 10-Q 2014-08-08
Q1 2014 $3.85M -$45.1K -1.16% Mar 31, 2014 10-Q 2014-05-12
Q4 2013 $3.54M -$424K -10.7% Dec 31, 2013 10-Q 2014-11-07
Q3 2013 $3.47M -$986K -22.1% Sep 30, 2013 10-Q 2013-11-06
Q2 2013 $3.2M -$233K -6.78% Jun 30, 2013 10-Q 2013-08-09
Q1 2013 $3.89M -$277K -6.64% Mar 31, 2013 10-Q 2013-05-08
Q4 2012 $3.96M +$110K +2.85% Dec 31, 2012 10-Q 2013-11-06
Q3 2012 $4.45M +$1.03M +30% Sep 30, 2012 10-Q 2012-11-02
Q2 2012 $3.43M +$1.19M +53.2% Jun 30, 2012 10-Q 2012-08-09
Q1 2012 $4.17M Mar 31, 2012 10-Q 2012-05-04
Q4 2011 $3.85M +$2.51M +188% Dec 31, 2011 10-Q 2012-11-02
Q3 2011 $3.42M Sep 30, 2011 10-Q 2011-11-07
Q2 2011 $2.24M Jun 30, 2011 10-Q 2011-08-08
Q4 2010 $1.34M Dec 31, 2010 10-K 2012-03-07
* An asterisk sign (*) next to the value indicates that the value is likely invalid.